Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Gross Profit: 2020-2025

Historic Gross Profit for iSpecimen (ISPC) over the last 6 years, with Sep 2025 value amounting to -$1.0 million.

  • iSpecimen's Gross Profit fell 193.37% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213,769, marking a year-over-year decrease of 104.29%. This contributed to the annual value of $4.0 million for FY2024, which is 21.92% down from last year.
  • As of Q3 2025, iSpecimen's Gross Profit stood at -$1.0 million, which was down 484.56% from $268,958 recorded in Q2 2025.
  • iSpecimen's 5-year Gross Profit high stood at $1.8 million for Q3 2021, and its period low was -$1.0 million during Q3 2025.
  • Moreover, its 3-year median value for Gross Profit was $1.1 million (2024), whereas its average is $782,462.
  • Per our database at Business Quant, iSpecimen's Gross Profit surged by 122.32% in 2024 and then crashed by 193.37% in 2025.
  • Over the past 5 years, iSpecimen's Gross Profit (Quarterly) stood at $1.3 million in 2021, then increased by 16.98% to $1.6 million in 2022, then dropped by 26.04% to $1.1 million in 2023, then plummeted by 86.81% to $151,352 in 2024, then slumped by 193.37% to -$1.0 million in 2025.
  • Its Gross Profit was -$1.0 million in Q3 2025, compared to $268,958 in Q2 2025 and $400,231 in Q1 2025.